Cardiovascular risk and treatment patterns in adults with type 2 diabetes in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

CardioMET is an observational, real-world registry enrolling adults with type 2 diabetes from internal medicine and cardiology outpatient clinics in Italy. It will collect clinical and pharmacological data to characterize patients' cardiovascular risk profiles and document management according to current ESC and AHA prevention guidelines. Eligible participants are adults with stable T2DM who can provide written informed consent, while type 1 diabetes, active participation in interventional trials, or conditions that increase participation risk are excluded. The collected data will be analyzed to identify patterns of care and gaps in guideline implementation to inform future quality-improvement efforts.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years;
* Diagnosis of type 2 diabetes mellitus (T2DM);
* Stable clinical conditions
* Outpatient settings
* Ability to understand the study procedures and provide written informed consent.

Exclusion Criteria:

* Patients with type 1 diabetes mellitus;
* Active participation in interventional studies;
* Any condition that may put the patient at risk by participating in the study.

Where it's running

• Federico II University of Naples, Department of Advanced Biomedical Sciences
  Naples, Napoli, Italy Recruiting

Study contacts

• Study coordinator: Pasquale Perrone Filardi
• Email: fpperron@unina.it
• Phone: +39081/746224

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.